Consuming more protein may protect patients taking anti-obesity drug from muscle loss
Selecting the most appropriate GLP-1 receptor agonist requires consideration of multiple patient-specific factors, clinical characteristics, and treatment goals
Several studies suggest that similar to lipids, reductions in food intake via intestinal protein in rodents are due to CCK release and subsequent activation of VANs, as (1) intestinal protein infusion increases CCK in rodents and humans 188,189
Homozygous NKO mice exhibit embryonic lethality [68], whereas heterozygous NKO mice exhibit IGT due to impaired insulin secretion [68] and heart failure due to progressive mitochondrial dysfunction induced by pressure overload [69]
Not everyone needs this highest dose
Se inicia con 0.25 mg semanalmente durante 4 semanas, seguido de aumentos mensuales: 0.5 mg (semanas 5-8), 1 mg (semanas 9-12), 1.7 mg (semanas 13-16), hasta alcanzar la dosis de mantenimiento de 2.4 mg semanales
